SPOKANE, Wash., Oct. 15, 2018 /PRNewswire/ -- Gestalt Diagnostics has added renowned Healthcare industry veteran Dr. Hoak,to serve as Medical Director. He will be responsible for leading Gestalt's distinguished Advisory Board of pathologists, for providing oversight, and for active management on development initiatives as they relate to compliance
Dr. Hoak, a board-certified Pathologist in Anatomic, Clinical and Cytopathology, has held many positions, including InCyte Diagnostics President and Medical Director where he led the expansion of the practice to become InCyte Pathology with over 40 pathologists located in 13 community hospitals, 14 rural hospitals and 4 laboratories. In addition, he has served as the President of multiple organizations, including the Washington State Society of Pathology, the Pacific Northwest Society of Pathology, the American Pathology Foundation, as well as holding a seat on government and economic affairs committees at the College of American Pathologists.
"We are thrilled Dr. Hoak is bringing his strong industry and operational leadership to Gestalt at a time when our digital pathology software solution is advancing in the market," said Dan Roark, chief executive officer, Gestalt. "Dr. Hoak has deep experience in pathology services, including the adoption of digital pathology at a large laboratory. His career-long focus on patient quality-of-care and physician well-being are an excellent fit with our vision and culture, which is dedicated to improving the speed and treatment of cancer – making a fundamental difference in patients' lives."
Dr. Hoak states, "I am excited and honored to be working with Gestalt Diagnostics. The current platforms and solutions they are developing add workflow efficiency and improve physician collaboration making the pathologist's job easier while increasing patient safety."
Gestalt Diagnostics is a private, profit-driven software company who has developed PathFlow, an enterprise software platform specifically designed to bring the benefits of digital workflow to pathologists and pathology laboratories. This product, originally developed by what is now Gestalt's team, supports a fully digital reading platform for radiology. The radiology platform is used in leading hospitals across the United States and supports more than 13 million studies annually. Gestalt has expanded and redesigned this proven, robust solution to work in the laboratory space – engineered for the unique needs and workflow of pathologists.
View original content:http://www.prnewswire.com/news-releases/industry-veteran-dr-david-hoak-joins-gestalt-diagnostics-as-medical-director-board-member-300729909.html
SOURCE Gestalt Diagnostics
Subscribe to our Free Newsletters!